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The human immunodeficiency virus (HIV) causes diverse dis-
orders of the brain, spinal cord and peripheral nerves.  Rarely, 
polymyositis and myoglobinuria are seen. Two other neuromus-
cular syndromes in people with HIV antibodies are nemaline 
myopathy and bibrachial amyotrophic diplegia, a form of mo-
tor neuron disease. The associations between these diseases and 
the possibility that HIV infection could be a risk factor for either 
amyotrophic lateral sclerosis (ALS) itself or other motor neuron 
diseases are investigated.
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Introduction
The  human  immunodeficiency  virus  (HIV)  causes 
diverse disorders of the brain, spinal cord and peripheral 
nerves. Rarely, polymyositis and myoglobinuria are seen. 
Two other neuromuscular syndromes in people with HIV 
antibodies are nemaline myopathy and bibrachial amyo-
trophic diplegia, a form of motor neuron disease. These 
associations have not been proven epidemiologically and 
it is uncertain whether HIV infection is a risk factor for 
either amyotrophic lateral sclerosis (ALS) itself or other 
motor neuron diseases. However, manifestations of ALS 
in people with HIV infection can be treated effectively 
with  Highly  Active  Antiretroviral  Therapy  (HAART), 
which would therefore be expected to lower the rate at 
which new cases appear.
Nemaline Myopathy
History: Drs. Engel and Askanas have been leaders in 
the study of nemaline myopathy and other conditions in 
which abnormal inclusions are found in muscle. Nemaline 
myopathy is defined by the clinical and histologic mani-
festations. It was named by G. Milton Shy, W. King Engel 
and their associates in 1963 (1). “Nemaline” was applied 
because muscle biopsies showed deposits of thread-like 
structures; the word came from the Greek “nema”. The 
threads were dark red with the Gomori stain and contain 
actin. The clinical syndromes are seen most often in in-
fants and children (2, 3). One form, however, occurs in 
adults, warranting the name “sporadic late onset nemaline 
myopathy” (SLONM) (4).
In infants and children, the disease is often familial 
in a pattern consistent with autosomal recessive inherit-
ance. In adults, the disease is almost always sporadic and 
is seen in association with other conditions (2). Here, we 
are considering the association of SLONM with HIV in-
fection.
“Sporadic Late-onset Nemaline Myopathy” (SLONM)
Clinical Manifestations: SLONM affects both sexes 
equally at ages ranging from 20 to 50. The most com-
mon clinical syndrome is one of proximal limb weakness 
of subacute onset and progression, sometimes severe and 
disabling. The neck extensors may be affected, resulting 
in the dropped head syndrome. Dysphagia and respiratory 
failure may appear. Tendon reflexes are usually absent. 
Fasciculation is not often seen but may be. Sometimes 
there is evidence of a second muscle disorder, which may 
be dermatomyositis or polymyositis. Progressive external 
ophthalmoplegia was reported in two patients (5, 6). The 
association with HIV was first described by Dalakas and 
associates (7). It is not clear how often patients with ne-
maline disease are HIV-positive.
Laboratory Findings: Diagnostic studies are usually 
indicative of myopathy but sometimes show evidence of 
denervation. By definition, the muscle biopsy must show 
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the deposits, which are seen as dark red. At the Mayo 
Clinic,
 
Chahin  et  al.  (2)
 
examined  3-µm-thick  frozen 
sections stained trichromatically or immunostained for 
α-actinin or myotilin. Electron microscopy in 12 cases 
identified the rods in all and revealed additional structural 
abnormalities. CK values were normal or low. Seven of 
their 14 patients had monoclonal gammopathy and were 
followed for 1 to 5 years; five died of respiratory fail-
ure. Five patients without monoclonal gammopathy were 
followed for 4 to 23 years and none died of the disease. 
The presence of gammopathy therefore may be ominous. 
HIV was excluded in 3 of 6 patients and the other 3 were 
deemed to have no HIV risk factors.
In other reports, a patient with monoclonal gammopa-
thy had features of both nemaline disease and “trabecular” 
or “lobulated” muscle fibers as well as biclonal gammopa-
thy (8). Another patient was being treated for dermatomy-
ositis when muscle biopsy showed nemaline rods (9).
Therapy: Immunosuppressive therapy with melpha-
lan, intravenous immunoglobulins (IVIG) or both may 
be helpful (2, 10-12) . Prednisone is sometimes effec-
tive (13, 14) but was uniformly ineffective in the Mayo 
report (2). Autologous stem therapy has also brought ben-
efit (15, 16). Long term immunosuppression with rituxi-
mab may be considered. Physical therapy is also indicated 
to maintain gait and general strength.
HIV and Motor Neuron Diseases
In 1985, the fourth year of the emerging AIDS epi-
demic, Hoffman et al. (17) described a 26 year old man 
with both upper and lower motor neuron signs. He was 
still alive a year later. Many feared there would be an 
epidemic of viral ALS. However, that fear was never 
realized. By mid-2002, there had been reports of 19 
patients with motor neuron disorders, with no evidence 
that HIV infection increases the likelihood of devel-
oping ALS. 13 of the 19 clearly had a disorder that 
was unlike ALS in one major way, the rapidity of pro-
gression. The time from onset of symptoms to severe 
handicap was measured in weeks and not months, too 
rapid for conventional ALS. One patient died 3 months 
after onset (18).
This  HIV-related  disorder  differed  in  other  ways, 
too. The patients were younger than most cases of mo-
tor neuron disease; only 2 of the 13 were older than age 
40 while only 10% of all cases of ALS begin before that 
age. Several of the patients had CSF pleocytosis, unlike 
ALS. CSF protein content was between 50 and 500 mg/
dl in most cases and exceeded 100 mg/dl in two. Two 
included dementia (19, 20) and one of the 13 had an IgM 
monoclonal gammopathy (5, 21). Among the 4 patients 
who came to autopsy, the pathology was more compli-
cated than ALS, with signs of inflammation or vacuolar 
myelopathy (22 23).
But the most remarkable difference from ALS was 
the reversal of symptoms by treatment with nucleosides 
or HAART (24-26). Some of these patients returned to 
normal neurologically. However, one patient’s symptoms 
progressed despite HAART therapy and we have seen 
one woman whose symptoms started after she had been 
on therapy for one year.
Therefore  ALS  in  HIV-positive  people  may  take 
either of two forms, one that responds to HAART and 
another that does not. The responsive form seems to be 
related to viral infection. Harbingers of therapeutic re-
sponse are young age at onset, progression in days or 
weeks, and abnormal CSF. The unresponsive form may 
be “ordinary” sporadic ALS that occurs by chance in an 
HIV-positive person.
A  purely  upper  motor  neuron  syndrome  has  also 
been reported in two HIV-positive patients. One proved to 
have progressive multifocal leucoencephalopathy (PML) 
but the other was compatible with primary lateral sclero-
sis (27). Two other patients had PML (28). A second vari-
ation of motor neuron disorder is “brachial amyotrophic 
diplegia”, which may affect HIV-positive people (29-31) 
(“man-in-a-barrel  syndrome”)  and  one  patient  showed 
lingual fasciculation with hyperreflexia; postmortem ex-
amination  showed  sarcoid  brainstem  encephalitis  (32). 
In contrast, one patient had the lower motor neuron syn-
drome of progressive muscular atrophy (33). One patient 
with brachial amyotrophy had an SOD1 mutation (34).
Recognition of these HIV-related motor neuron syn-
dromes is important because they may respond to treat-
ment. These  syndromes  also  raise  theoretical  issues  – 
whether sporadic ALS could ever be caused by a virus or 
autoimmunity. It is still not known how HIV might cause 
a motor neuron disorder (35).
Conclusion
Both nemaline myopathy and motor neuron disease 
may be associated with HIV. Treatment of the myopathy 
with prednisone may or may not be effective but can be 
tried. HAART may be neurologically effective in HIV 
patients with ALS. These responses to treatment warrant 
consideration in planning diagnostic studies.
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